Fang Yong, Shang Qing-Long, Liu Jian-Yu, Li Di, Xu Wei-Zhen, Teng Xu, Zhao Hong-Wei, Fu Li-Juan, Zhang Feng-Min, Gu Hong-Xi
Department of Microbiology, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin, Heilongjiang Province 150081, China.
J Infect. 2009 May;58(5):383-8. doi: 10.1016/j.jinf.2009.02.013. Epub 2009 Mar 29.
To investigate the prevalence of occult hepatitis B virus (HBV) infection among hepatopathy patients and healthy people in China.
The HBV DNA in 653 sera samples collected from cryptogenic chronic liver disease patients (159), hepatitis B surface antigen (HBsAg) negative hepatocellular carcinoma (HCC) patients (135) and HBsAg-negative healthy people (359) were tested by nested PCR using specific primers of the X region of the HBV genome. We performed real-time PCR to determine the levels of serum HBV-DNA.
Prevalence of occult HBV infection was 28.3% (45/159), 70.4% (95/135) and 10.6% (38/359) in cryptogenic chronic liver disease patients, HBsAg-negative HCC patients and HBsAg-negative healthy people, respectively. The prevalence of occult HBV infection in IgG anti-HBc-positive subjects was 100% (45/45), 86.7% (85/98) and 33.3% (14/42) in cryptogenic chronic liver disease patients, HBsAg-negative HCC patients and HBsAg-negative healthy people, respectively. In all cases, viral loads were low (<10(4)viral copies/mL).
The prevalence of occult HBV infection was significantly high among hepatopathy patients and healthy people in China. Thus, more meticulous attention should be given to prevent HBV transmission by blood transfusion or organ transplantation in endemic areas, and further studies on clinical implication and mechanism of occult HBV infection are required.
调查中国肝病患者和健康人群中隐匿性乙型肝炎病毒(HBV)感染的流行情况。
采用巢式PCR法,使用HBV基因组X区特异性引物,检测653份血清样本中的HBV DNA,这些样本分别来自原因不明的慢性肝病患者(159例)、乙型肝炎表面抗原(HBsAg)阴性的肝细胞癌(HCC)患者(135例)和HBsAg阴性的健康人(359例)。我们进行实时PCR以确定血清HBV-DNA水平。
原因不明的慢性肝病患者、HBsAg阴性的HCC患者和HBsAg阴性的健康人中隐匿性HBV感染的发生率分别为28.3%(45/159)、70.4%(95/135)和10.6%(38/359)。在IgG抗-HBc阳性受试者中,原因不明的慢性肝病患者、HBsAg阴性的HCC患者和HBsAg阴性的健康人中隐匿性HBV感染的发生率分别为100%(45/45)、86.7%(85/98)和33.3%(14/42)。在所有病例中,病毒载量均较低(<10⁴病毒拷贝/mL)。
中国肝病患者和健康人群中隐匿性HBV感染的发生率显著较高。因此,在流行地区应更加细致地关注预防输血或器官移植导致的HBV传播,并且需要对隐匿性HBV感染的临床意义和机制进行进一步研究。